Cargando…
Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition)
Portal vein tumor thrombus (PVTT) is very common and it plays a major role in the prognosis and clinical staging of hepatocellular carcinoma (HCC). We have published the first version of the guideline in 2016 and revised in 2018. Over the past several years, many new evidences for the treatment of P...
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
S. Karger AG
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294940/ https://www.ncbi.nlm.nih.gov/pubmed/35978596 http://dx.doi.org/10.1159/000523997 |
| _version_ | 1784749958348406784 |
|---|---|
| author | Sun, Juxian Guo, Rongping Bi, Xinyu Wu, Mengchao Tang, Zhaoyou Lau, Wan Yee Zheng, Shusen Wang, Xuehao Yu, Jinming Chen, Xiaoping Fan, Jia Dong, Jiahong Chen, Yongjun Cui, Yunfu Dai, Chaoliu Fang, Chihua Feng, Shuang Ji, Zhili Jia, Weidong Jia, Ningyang Li, Gong Li, Jing Li, Qiu Li, Jiangtao Liang, Tingbo Liu, Lianxin Lu, Shichun Lv, Yi Mao, Yilei Meng, Yan Meng, Zhiqiang Shen, Feng Shi, Jie Sun, Huichuan Tao, Kaishan Teng, Gaojun Wan, Xuying Wen, Tianfu Wu, Liqun Xia, Jinglin Ying, Mingang Zhai, Jian Zhang, Leida Zhang, Xuewen Zhang, Zhiwei Zhao, Haiping Zheng, Donghai Zhi, Xuting Zhou, Jie Zhou, Cuncai Zhou, Jian Zeng, Zhaochong Zhu, Kangshun Chen, Minshan Cai, Jianqiang Cheng, Shuqun |
| author_facet | Sun, Juxian Guo, Rongping Bi, Xinyu Wu, Mengchao Tang, Zhaoyou Lau, Wan Yee Zheng, Shusen Wang, Xuehao Yu, Jinming Chen, Xiaoping Fan, Jia Dong, Jiahong Chen, Yongjun Cui, Yunfu Dai, Chaoliu Fang, Chihua Feng, Shuang Ji, Zhili Jia, Weidong Jia, Ningyang Li, Gong Li, Jing Li, Qiu Li, Jiangtao Liang, Tingbo Liu, Lianxin Lu, Shichun Lv, Yi Mao, Yilei Meng, Yan Meng, Zhiqiang Shen, Feng Shi, Jie Sun, Huichuan Tao, Kaishan Teng, Gaojun Wan, Xuying Wen, Tianfu Wu, Liqun Xia, Jinglin Ying, Mingang Zhai, Jian Zhang, Leida Zhang, Xuewen Zhang, Zhiwei Zhao, Haiping Zheng, Donghai Zhi, Xuting Zhou, Jie Zhou, Cuncai Zhou, Jian Zeng, Zhaochong Zhu, Kangshun Chen, Minshan Cai, Jianqiang Cheng, Shuqun |
| author_sort | Sun, Juxian |
| collection | PubMed |
| description | Portal vein tumor thrombus (PVTT) is very common and it plays a major role in the prognosis and clinical staging of hepatocellular carcinoma (HCC). We have published the first version of the guideline in 2016 and revised in 2018. Over the past several years, many new evidences for the treatment of PVTT become available, especially for the advent of new targeted drugs and immune checkpoint inhibitors which have further improved the prognosis of PVTT. So, the Chinese Association of Liver Cancer and Chinese Medical Doctor Association revised the 2018 version of the guideline to adapt to the development of PVTT treatment. Future treatment strategies for HCC with PVTT in China would depend on new evidences from more future clinical trials. |
| format | Online Article Text |
| id | pubmed-9294940 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | S. Karger AG |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92949402022-08-16 Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition) Sun, Juxian Guo, Rongping Bi, Xinyu Wu, Mengchao Tang, Zhaoyou Lau, Wan Yee Zheng, Shusen Wang, Xuehao Yu, Jinming Chen, Xiaoping Fan, Jia Dong, Jiahong Chen, Yongjun Cui, Yunfu Dai, Chaoliu Fang, Chihua Feng, Shuang Ji, Zhili Jia, Weidong Jia, Ningyang Li, Gong Li, Jing Li, Qiu Li, Jiangtao Liang, Tingbo Liu, Lianxin Lu, Shichun Lv, Yi Mao, Yilei Meng, Yan Meng, Zhiqiang Shen, Feng Shi, Jie Sun, Huichuan Tao, Kaishan Teng, Gaojun Wan, Xuying Wen, Tianfu Wu, Liqun Xia, Jinglin Ying, Mingang Zhai, Jian Zhang, Leida Zhang, Xuewen Zhang, Zhiwei Zhao, Haiping Zheng, Donghai Zhi, Xuting Zhou, Jie Zhou, Cuncai Zhou, Jian Zeng, Zhaochong Zhu, Kangshun Chen, Minshan Cai, Jianqiang Cheng, Shuqun Liver Cancer Guidelines Portal vein tumor thrombus (PVTT) is very common and it plays a major role in the prognosis and clinical staging of hepatocellular carcinoma (HCC). We have published the first version of the guideline in 2016 and revised in 2018. Over the past several years, many new evidences for the treatment of PVTT become available, especially for the advent of new targeted drugs and immune checkpoint inhibitors which have further improved the prognosis of PVTT. So, the Chinese Association of Liver Cancer and Chinese Medical Doctor Association revised the 2018 version of the guideline to adapt to the development of PVTT treatment. Future treatment strategies for HCC with PVTT in China would depend on new evidences from more future clinical trials. S. Karger AG 2022-03-17 /pmc/articles/PMC9294940/ /pubmed/35978596 http://dx.doi.org/10.1159/000523997 Text en Copyright © 2022 by The Author(s). Published by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. |
| spellingShingle | Guidelines Sun, Juxian Guo, Rongping Bi, Xinyu Wu, Mengchao Tang, Zhaoyou Lau, Wan Yee Zheng, Shusen Wang, Xuehao Yu, Jinming Chen, Xiaoping Fan, Jia Dong, Jiahong Chen, Yongjun Cui, Yunfu Dai, Chaoliu Fang, Chihua Feng, Shuang Ji, Zhili Jia, Weidong Jia, Ningyang Li, Gong Li, Jing Li, Qiu Li, Jiangtao Liang, Tingbo Liu, Lianxin Lu, Shichun Lv, Yi Mao, Yilei Meng, Yan Meng, Zhiqiang Shen, Feng Shi, Jie Sun, Huichuan Tao, Kaishan Teng, Gaojun Wan, Xuying Wen, Tianfu Wu, Liqun Xia, Jinglin Ying, Mingang Zhai, Jian Zhang, Leida Zhang, Xuewen Zhang, Zhiwei Zhao, Haiping Zheng, Donghai Zhi, Xuting Zhou, Jie Zhou, Cuncai Zhou, Jian Zeng, Zhaochong Zhu, Kangshun Chen, Minshan Cai, Jianqiang Cheng, Shuqun Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition) |
| title | Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition) |
| title_full | Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition) |
| title_fullStr | Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition) |
| title_full_unstemmed | Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition) |
| title_short | Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition) |
| title_sort | guidelines for diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus in china (2021 edition) |
| topic | Guidelines |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294940/ https://www.ncbi.nlm.nih.gov/pubmed/35978596 http://dx.doi.org/10.1159/000523997 |
| work_keys_str_mv | AT sunjuxian guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT guorongping guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT bixinyu guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT wumengchao guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT tangzhaoyou guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT lauwanyee guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT zhengshusen guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT wangxuehao guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT yujinming guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT chenxiaoping guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT fanjia guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT dongjiahong guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT chenyongjun guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT cuiyunfu guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT daichaoliu guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT fangchihua guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT fengshuang guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT jizhili guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT jiaweidong guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT jianingyang guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT ligong guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT lijing guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT liqiu guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT lijiangtao guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT liangtingbo guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT liulianxin guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT lushichun guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT lvyi guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT maoyilei guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT mengyan guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT mengzhiqiang guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT shenfeng guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT shijie guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT sunhuichuan guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT taokaishan guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT tenggaojun guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT wanxuying guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT wentianfu guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT wuliqun guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT xiajinglin guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT yingmingang guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT zhaijian guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT zhangleida guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT zhangxuewen guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT zhangzhiwei guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT zhaohaiping guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT zhengdonghai guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT zhixuting guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT zhoujie guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT zhoucuncai guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT zhoujian guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT zengzhaochong guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT zhukangshun guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT chenminshan guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT caijianqiang guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition AT chengshuqun guidelinesfordiagnosisandtreatmentofhepatocellularcarcinomawithportalveintumorthrombusinchina2021edition |